An Ohio man has filed a federal product liability lawsuit against a West Virginia pharmaceutical company after he reportedly suffered severe side effects as a result of taking Digitek, a recently recalled pharmaceutical drug designed as a heart medicine manufactured by Actavis Totowa LLC. The medicine also known as Digoxin, is distributed by Mylan Pharmaceuticals, according to this news report. Earlier this year, Actavis Totowa LLC recalled all lots Digitek because the tablets contained twice the approved level of the active ingredient.
The lawsuit states that there have been at least 11 complaints relating to Digitek’s side effects, including illnesses and injuries, since 2006. Joe Supinski, who filed the lawsuit, said he started taking the drug for an irregular heart rhythm, but after taking the prescribed dosage, he reportedly experienced visual changes, blurred vision, loss of appetite, low blood pressure, breathing difficulties and other health problems.
Mr. Supinski was not alone in his suffering. Bobbie Dyal and Robert Dyal, an Alabama couple, are also filing a similar lawsuit against the drug manufacturer. According to this lawsuit, Bobbie Dyal suffered permanent heart damage because of digitalis toxicity, a lethal reaction to Digoxin overdose.
We have a number of clients who lost a family member to Digitek (Digoxin) overdose caused by the double dosage of the active ingredient by the manufacturer. We have been in contact with even more people who believe that they have suffered severe side effects from the drug and are considering filing lawsuits. We are in the process of gathering the medical evidence to substantiate their pharmaceutical litigation cases before filing our own lawsuits.
Continue reading "Digitek (Digoxin) Product Liability Lawsuits Filed Against Actavis Totowa" »